NMPA Approval

Compound Theophylline and Ephedrine Tablets

Approval Number

国药准字H22026031

Company长春新安药业有限公司

Registration Date

June 4, 2020

Drug Information

Generic Name

复方茶碱麻黄碱片

Dosage Form

片剂

Strength

复方

Drug Type

化学药品

Registration Date

June 4, 2020

Company Information

Applicant Company

Company Name长春新安药业有限公司

Manufacturing Company

Company Name长春新安药业有限公司

Company Address

长春合隆经济开发区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.